WebDisclosure WebDisclosure
Basculer en Français
9473 Companies
185387 Keywords
117733 Articles
99269 Press releases
Headlines Articles Press releases VisiRose Remove
  1. Home
  2. Companies
  3. VisiRose
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/10/2024 at 13:35, 11 months 25 days ago

    VisiRose Launches Innovative Eye Infection Therapy RB PDAT

    Biotechnology Antimicrobial Resistance VisiRose RB PDAT Eye Infections
  • BRIEF

    published on 12/10/2024 at 13:35, 11 months 25 days ago

    VisiRose lance une thérapie innovante contre les infections oculaires RB PDAT

    Biotechnologie Résistance Aux Antimicrobiens VisiRose RB PDAT Infections Oculaires
  • PRESS RELEASE

    published on 12/10/2024 at 13:30, 11 months 25 days ago

    VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

    VisiRose, a clinical-stage biotechnology company, collaborates with Bascom Palmer Eye Institute to introduce Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT) for eye infections. The innovative treatment addresses antimicrobial resistance and offers hope for patients worldwide
    Innovative Treatment VisiRose RB PDAT Eye Infections Bascom Palmer Eye Institute
    Logo of VisiRose
Accesswire
  • Published on 12/05/2025 at 02:35, 5 hours 37 minutes ago

    Future Fuels Initates Drill Permitting at Hornby; Marketing Update

  • Published on 12/05/2025 at 02:30, 5 hours 42 minutes ago

    Klondike Gold Announces AGM Results

  • Published on 12/05/2025 at 01:00, 7 hours 12 minutes ago

    BEACN Closes First Tranche of Non-Brokered Private Placement

  • Published on 12/04/2025 at 23:05, 9 hours 7 minutes ago

    BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025

  • Published on 12/04/2025 at 23:00, 9 hours 12 minutes ago

    NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE
EQS Group
  • Published on 12/05/2025 at 08:05, 7 minutes ago

    Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes

  • Published on 12/05/2025 at 08:01, 11 minutes ago

    Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):

  • Published on 12/05/2025 at 08:01, 11 minutes ago

    Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025

  • Published on 12/05/2025 at 08:00, 12 minutes ago

    Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing

  • Published on 12/05/2025 at 08:00, 12 minutes ago

    Le Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) croît et est sur le point de franchir la barre des 500 millions

View all EQS
Les Echos
  • Published on 12/04/2025 at 18:14, 13 hours 57 minutes ago

    Résiliation d'une convention conclue entre actionnaires

  • Published on 12/04/2025 at 18:00, 14 hours 12 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

  • Published on 12/04/2025 at 18:00, 14 hours 12 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025

  • Published on 12/04/2025 at 17:45, 14 hours 27 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions

  • Published on 12/04/2025 at 17:45, 14 hours 27 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy